In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...
German drugmaker Evotec is attracting takeover interest from U.S.-based Halozyme Therapeutics , Bloomberg News reported on Thursday.
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback